Sanofi SA (EPA:SAN) has been given a €74.00 ($82.22) price objective by Jefferies Group in a note issued to investors on Thursday. The brokerage presently has a a “neutral” rating on the stock.

Other analysts have also recently issued research reports about the stock. Berenberg Bank set a €93.00 ($103.33) price target on shares of Sanofi SA and gave the company a “buy” rating in a report on Thursday, September 8th. Kepler Capital Markets set a €89.00 ($98.89) price target on shares of Sanofi SA and gave the company a “buy” rating in a report on Thursday, August 11th. Societe Generale set a €100.00 ($111.11) price target on shares of Sanofi SA and gave the company a “buy” rating in a report on Monday, August 1st. Independent Research GmbH set a €77.00 ($85.56) price target on shares of Sanofi SA and gave the company a “neutral” rating in a report on Thursday, June 30th. Finally, BNP Paribas set a €78.00 ($86.67) price target on shares of Sanofi SA and gave the company a “neutral” rating in a report on Wednesday, September 14th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the company’s stock. Sanofi SA currently has a consensus rating of “Hold” and an average price target of €86.65 ($96.27).

Analyst Recommendations for Sanofi SA (EPA:SAN)

Shares of Sanofi SA (EPA:SAN) opened at 67.59 on Thursday. The firm has a 50-day moving average of €25.98 and a 200-day moving average of €25.76. Sanofi SA has a 52 week low of €22.81 and a 52 week high of €68.17. The firm has a market cap of €86.99 billion and a PE ratio of 21.02.

Sanofi SA Company Profile

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.

Receive News & Stock Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related stocks with our FREE daily email newsletter.